In recent research, Xia et al. found that AFAP1-AS1 suppresses cancer stemness, cell cycle progression, and EMT in CD44v6 (+) CC cells, and that the miR-27b-3p/VEGF-C axis is a direct target of AFAP1-AS1, allowing AFAP1-AS1 to modulate stemness characteristics in CC cells [172]. The gene discussed is AFAP1; the disease is cancer.